TD Synnex
SNX
271.52
-6.86
-2.46%
TD Synnex
US · SNX
#917 by market cap
Listed 1970
271.52
-6.86
-2.46%
Live - 5344 symbols - heartbeat 401s ago
· 2026-10-08 07:38
Pre-market
271.52
0.00%
After-hours
271.50
-0.01%
- Market cap
- 21.66B
- P/E (TTM)i
- 16.56
- P/Bi
- 2.33
- EPSi
- 9.95
- Div yieldi
- 0.69%
- 52W posi
- 83%
Reader sentiment
Are you bullish or bearish on SNX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.76, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +6.94% YoY
Margins
- Gross margin
- 6.99%
- Operating margin
- 2.28%
- Net margin
- 1.31%
Key ratios & quality
- Enterprise valuei
- 23.84B
- PEG ratioi
- 1.99
- Altman Z-Scorei
- 2.76
PEG uses trailing P/E against the 3-year net income growth rate (8.32%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 19.77B | 19.07B | 19.98B | 31.61B | 62.34B | 57.56B | 58.45B | 62.51B |
| Gross profit | 1.93B | 1.16B | 1.19B | 1.89B | 3.90B | 3.96B | 3.98B | 4.37B |
| Selling & admin expenses | 1.38B | 636.85M | 665.10M | 1.15B | 2.63B | 2.67B | 2.72B | 2.95B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 550.24M | 520.41M | 528.76M | 735.37M | 1.27B | 1.28B | 1.27B | 1.42B |
| Pretax profit | 456.58M | 473.29M | 436.15M | 466.49M | 827.13M | 789.51M | 866.04M | 1.06B |
| Tax | 156.60M | 111.11M | 101.61M | 71.42M | 175.82M | 162.60M | 176.94M | 229.59M |
| Net profit | 299.98M | 500.71M | 529.16M | 395.07M | 651.31M | 626.91M | 689.09M | 827.66M |
| Basic EPS | 7 | 10 | 10 | 6 | 7 | 7 | 8 | 10 |
| Diluted EPS | 7.17 | 9.74 | 10.21 | 6.24 | 6.77 | 6.70 | 7.95 | 9.95 |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Revenue | 14.95B | 15.65B | 17.38B | 17.16B | 19.57B | 21.56B |
| Gross profit | 1.05B | 1.13B | 1.19B | 1.25B | 1.34B | 1.43B |
| Selling & admin expenses | 718.23M | 743.89M | 792.94M | 762.79M | 820.10M | 782.54M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 328.14M | 385.96M | 401.81M | 489.36M | 519.36M | 642.88M |
| Pretax profit | 238.08M | 293.26M | 311.03M | 422.41M | 429.93M | 555.25M |
| Tax | 53.16M | 66.47M | 62.63M | 95.49M | 95.85M | 139.01M |
| Net profit | 184.92M | 226.80M | 248.41M | 326.92M | 334.09M | 416.24M |
| Basic EPS | 2 | 3 | 3 | 4 | 4 | 5 |
| Diluted EPS | 2.21 | 2.74 | 3.04 | 4.04 | 4.15 | 5.18 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 7.16B | 7.45B | 8.77B | 17.73B | 20.50B | 20.08B | 21.32B | 25.29B |
| Cash & ST investments | 454.69M | 225.53M | 1.41B | 993.97M | 522.60M | 1.03B | 1.06B | 2.44B |
| Inventory | 2.39B | 2.55B | 2.68B | 6.64B | 9.07B | 7.15B | 8.29B | 9.50B |
| Total assets | 11.54B | 11.70B | 13.47B | 27.67B | 29.73B | 29.41B | 30.27B | 34.25B |
| Total current liabilities | 4.95B | 4.61B | 5.63B | 14.23B | 16.43B | 16.74B | 17.22B | 20.96B |
| Short-term debt | 833.22M | 298.97M | 124.96M | 181.26M | 268.13M | 983.59M | 171.09M | 1.02B |
| Long-term debt | 2.62B | 2.72B | 1.50B | 3.96B | 3.84B | 3.10B | 3.74B | 3.59B |
| Total liabilities | 8,108,444,000.00 | 7,909,510,000.00 | 9,129,730,000.00 | 19,760,405,000.00 | 21,708,492,000.00 | 21,229,632,000.00 | 22,239,045,000.00 | 25,800,469,000.00 |
| Total equity | 3.44B | 3.79B | 4.34B | 7.91B | 8.03B | 8.18B | 8.04B | 8.45B |
| Retained earnings | 2.20B | 2.62B | 3.13B | 1.17B | 1.71B | 2.20B | 2.76B | 3.44B |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Total current assets | 21.49B | 22.58B | 25.29B | 26.11B | 29.59B | 32.89B |
| Cash & ST investments | 767.10M | 874.35M | 2.44B | 1.56B | 1.09B | 749.30M |
| Inventory | 8.66B | 9.14B | 9.50B | 10.98B | 13.89B | 15.29B |
| Total assets | 30.51B | 31.68B | 34.25B | 35.08B | 38.51B | 41.84B |
| Total current liabilities | 17.12B | 18.88B | 20.96B | 21.44B | 24.67B | 27.61B |
| Short-term debt | 382.43M | 1.19B | 1.02B | 1.13B | 1.13B | 1.93B |
| Long-term debt | 3.72B | 3.04B | 3.59B | 3.59B | 3.59B | 3.60B |
| Total liabilities | 22,166,815,000.00 | 23,229,401,000.00 | 25,800,469,000.00 | 26,300,969,000.00 | 29,555,654,000.00 | 32,542,680,000.00 |
| Total equity | 8.34B | 8.45B | 8.45B | 8.78B | 8.95B | 9.30B |
| Retained earnings | 3.03B | 3.22B | 3.44B | 3.73B | 4.02B | 4.40B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 100.71M | 549.92M | 1.83B | 809.79M | -49.60M | 1.41B | 1.22B | 1.53B |
| Depreciation & amortization | 225.29M | 372.11M | 341.64M | 151.66M | 463.37M | 418.32M | 407.53M | 414.22M |
| Free cash flow | -24.60M | 412.50M | 1.64B | 754.90M | -166.65M | 1.26B | 1.04B | 1.39B |
| Dividends paid | -59.72M | -76.61M | -20.78M | -50.27M | -114.95M | -130.37M | -138.08M | -146.38M |
| Stock buybacks / issuance | -67.48M | -17.73M | -5.68M | 2.87M | -127.84M | -630.74M | -624.60M | -593.59M |
| Ending cash balance | 462.03M | 231.15M | 1.57B | 994.91M | 522.86M | 1.03B | 1.06B | 2.44B |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Operating cash flow | 573.18M | 246.14M | 1.46B | -895.87M | -265.61M | -916.72M |
| Depreciation & amortization | 103.60M | 105.84M | 105.08M | 104.68M | 105.28M | 106.24M |
| Free cash flow | 542.94M | 213.92M | 1.42B | -929.01M | -332.43M | -975.60M |
| Dividends paid | -36.90M | -36.30M | -35.96M | -38.74M | -38.53M | -38.38M |
| Stock buybacks / issuance | -150.67M | -159.46M | -188.48M | -64.70M | -111.75M | -89.12M |
| Ending cash balance | 767.10M | 874.35M | 2.44B | 1.56B | 1.09B | 749.30M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 10.42 | 13.74 | 12.88 | 6.39 | 8.12 | 7.68 | 8.42 | 9.95 |
| ROA %i | 3.11 | 4.28 | 4.16 | 1.90 | 2.25 | 2.10 | 2.29 | 2.54 |
| ROIC %i | 6.36 | 9.04 | 8.90 | 5.48 | 6.80 | 6.98 | 7.74 | 8.79 |
| 5-year avg ROE %i | 12.04 | 12.47 | 12.66 | 11.47 | 10.30 | 9.76 | 8.70 | 8.11 |
| EBIT margin %i | 2.70 | 3.55 | 3.37 | 1.97 | 1.68 | 1.87 | 2.03 | 2.26 |
| FCF / sales %i | -- | 1.74 | 6.63 | 2.39 | -- | 2.18 | 1.78 | 2.22 |
| Current ratioi | 1.45 | 1.62 | 1.56 | 1.25 | 1.25 | 1.20 | 1.24 | 1.21 |
| Quick ratioi | 0.90 | 0.98 | 0.80 | 0.73 | 0.66 | 0.73 | 0.72 | 0.72 |
| Debt / assetsi | 29.94 | 25.79 | 12.04 | 14.95 | 13.80 | 13.88 | 12.91 | 13.46 |
| LT debt / equityi | 76.35 | 71.75 | 34.50 | 50.03 | 47.79 | 37.87 | 46.50 | 42.51 |
| Interest coveragei | 6.40 | 5.07 | 6.53 | 3.96 | 4.72 | 3.74 | 3.71 | 3.96 |
| Revenue CAGR (3Y) %i | 14.01 | 10.69 | 6.00 | 16.94 | 48.42 | 42.29 | 22.74 | 0.09 |
| Net income CAGR (3Y) %i | 12.89 | 28.69 | 20.79 | 9.61 | 9.16 | 5.81 | 20.37 | 8.32 |
| FCF CAGR (3Y) %i | -- | 26.98 | 174.38 | -- | -- | -8.41 | 11.36 | -- |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| ROE %i | 8.83 | 9.23 | 9.95 | 11.62 | 13.02 | 14.91 |
| ROA %i | 2.47 | 2.52 | 2.54 | 3.06 | 3.26 | 3.60 |
| ROIC %i | 7.95 | 8.41 | 8.79 | 9.70 | 10.79 | 11.82 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 2.09 | 2.20 | 2.26 | 2.49 | 2.61 | 2.79 |
| FCF / sales %i | 1.01 | 0.79 | 2.22 | 1.92 | 0.54 | -- |
| Current ratioi | 1.26 | 1.20 | 1.21 | 1.22 | 1.20 | 1.19 |
| Quick ratioi | 0.69 | 0.67 | 0.72 | 0.67 | 0.60 | 0.60 |
| Debt / assetsi | 13.46 | 13.38 | 13.46 | 13.46 | 12.26 | 13.20 |
| LT debt / equityi | 44.63 | 36.01 | 42.51 | 40.91 | 40.16 | 38.65 |
| Interest coveragei | 3.64 | 3.77 | 3.96 | 4.56 | 5.01 | 5.38 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Americas Distribution is the largest reported line at 48.76% of revenue, across 4 reported segments.
- Europe Distribution follows at 30.88%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Americas Distribution48.76%
Europe Distribution30.88%
Hyve Solutions15.15%
Asia-Pacific and Japan (APJ) distribution5.21%
Quote time 2026-10-08 07:38:13 · For reference only, not investment advice and not tailored to your situation.